Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Endomagnetics receives IDE approval to initiate US trials

Abstract:
Cancer healthcare company Endomagnetics announced today that it has received Investigational Device Exemption (IDE) approval from the United States Food and Drug Administration (FDA) to initiate a pivotal clinical trial to evaluate the safety and effectiveness of the SentiMag® and Sienna+® magnetic sentinel lymph node biopsy system in the management of breast cancer.

Endomagnetics receives IDE approval to initiate US trials

Cambridge, UK | Posted on December 5th, 2014

The SentiMag® and Sienna+® system gives surgeons the ability to locate the sentinel lymph nodes draining a tumour accurately and reliably as part of cancer staging - the process of determining whether cancer has spread.

The system has already been tested in 10 clinical trials across Europe, involving more than 1,700 breast cancer patients, and published results have shown that the magnetic technique is safe, and clinically equivalent to the current gold standard for sentinel lymph node detection.

Dr Quentin Harmer, CTO of Endomagnetics, commented: "The IDE approval is a key step towards bringing this technology to US patients and builds on our European approval. By removing the requirement for radioactive isotopes, we can significantly improve the availability and convenience of the cancer staging procedure for patients and surgeons."

The multisite pivotal trial is expected to start in January 2015 with six hospitals participating from across the US. The trial is designed to collect safety and effectiveness data to support the future submission of a premarket approval (PMA) application to the FDA for SentiMag® and Sienna+®.

Dr Harmer continued: "Patient comfort and quality of life are behind everything we do, and our goal is to make our products accessible to as wide an audience as possible. In 2011 Sienna+® was the first tracer to gain Europe-wide CE mark approval for localising lymph nodes. The unique magnetic technology means that patients can now access an approved non-radioactive approach for this important cancer staging procedure. I am delighted that in just two years, already more than 3,000 patients across Europe have benefitted from this revolutionary technology."

####

For more information, please click here

Contacts:
Charlie Hopkinson
Senior PR
Account Executive
T: 01223 841699
F: 01223 845020
M: 07824 358235
Website: www.mobas.com
Twitter: @mobaspr
LinkedIn: MobasLtd
Find us on Facebook

Copyright © Endomagnetics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Cancer

University of Toronto researchers discover new lipid nanoparticle that shows muscle-specific mRNA delivery, reduces off-target effects: Study findings make significant contribution to generating tissue-specific ionizable lipids and prompts rethinking of mRNA vaccine design princi December 8th, 2023

Super-efficient laser light-induced detection of cancer cell-derived nanoparticles: Skipping ultracentrifugation, detection time reduced from hours to minutes! October 6th, 2023

The medicine of the future could be artificial life forms October 6th, 2023

Chung-Ang University researchers develop novel DNA biosensor for early diagnosis of cervical cancer: The electrochemical sensor, made of a graphitic nano-onion/molybdenum disulfide nanosheet composite, detects human papillomavirus (HPV)-16 and HPV-18, with high specificity September 8th, 2023

Govt.-Legislation/Regulation/Funding/Policy

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Researchers’ approach may protect quantum computers from attacks March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Optically trapped quantum droplets of light can bind together to form macroscopic complexes March 8th, 2024

Nanomedicine

High-tech 'paint' could spare patients repeated surgeries March 8th, 2024

Researchers develop artificial building blocks of life March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project